Evidence map›Paper›PMID 36615461›Full record

ArticleMolecules (Basel, Switzerland)2022

Green Synthesized Zinc Oxide Nanoparticles Based on

Ibrahim N Alrabayah, Seham S Elhawary, Zeinab A Kandil, Essam M Abd El-Kadder, Yasmine S Moemen, Abdulrahman M Saleh, Mohamed A El Raey

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ibrahim N AlrabayahPharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza 11562, Egypt.
Seham S ElhawaryPharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza 11562, Egypt.
Zeinab A KandilPharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza 11562, Egypt.
Essam M Abd El-KadderTrees Research Department, Horticulture Research Institute, Agriculture Research Center, Giza 12619, Egypt.
Yasmine S MoemenClinical Pathology Department, National Liver Institute, Menoufia University, Menoufia 32511, Egypt.
Abdulrahman M SalehPharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 71524, Egypt.ORCID 0000-0002-5153-7399
Mohamed A El RaeyPhytochemistry and Plant Systematics, National Research Centre, Dokki, Cairo 12622, Egypt.ORCID 0000-0002-5960-3012

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 has caused more than 596 million infections and 6 million fatalities globally. Looking for urgent medication for prevention, treatment, and rehabilitation is obligatory. Plant extracts and green synthesized nanoparticles have numerous biological activities, including antiviral activity. HPLC analysis of

Indexed as

CestrumCOVID-19Metal NanoparticlesNanoparticlesZinc OxideAnti-Bacterial AgentsAntiviral AgentsHumansMicrobial Sensitivity TestsMolecular Docking SimulationPlant ExtractsSARS-CoV-2ZincAnti-Bacterial AgentsAntiviral AgentsPlant ExtractsZincZinc Oxideantiviral activityCestrum diurnum L.coronavirusesHPLC quantificationhuman corona 229Ezinc oxide nanoparticles

Identifiers

PMID36615461
PMCPMC9822259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.